## Differentiating Pernicious Anemia from Gastric Cancer in Achlorhydria **Key Point:** Gastric biopsy with histopathology is the most appropriate investigation to differentiate pernicious anemia (autoimmune gastritis with atrophy) from gastric cancer presenting with achlorhydria. Biopsy directly visualizes the gastric mucosa, identifies malignancy, and distinguishes between autoimmune atrophic gastritis and neoplastic causes. ### Clinical Context: Why Differentiation Matters Both pernicious anemia and gastric cancer can present with: - Achlorhydria (gastric pH >6) - Elevated fasting gastrin (due to loss of acid feedback) - Weight loss and GI symptoms - Endoscopic abnormalities However, the management and prognosis are entirely different. Biopsy is essential to exclude malignancy. ### Diagnostic Approach to Achlorhydria with Hypergastrinemia | Investigation | Pernicious Anemia | Gastric Cancer | Gastrinoma | |---|---|---|---| | **Gastric pH** | >6 (achlorhydria) | >6 (achlorhydria) | <2 (high acid) | | **Serum gastrin** | Elevated (>100) | Elevated (>100) | Elevated (often >1000) | | **Secretin stimulation** | No paradoxical rise | No paradoxical rise | Paradoxical rise >200 | | **Gastric biopsy** | Atrophic mucosa, no malignancy | Adenocarcinoma cells | Normal or hyperplastic mucosa | | **Intrinsic factor antibody** | Positive (60–70%) | Negative | Negative | | **Anti-parietal cell antibody** | Positive (90%) | Negative | Negative | **High-Yield:** Gastric biopsy is the gold standard for identifying gastric malignancy and is mandatory in any patient with achlorhydria and alarm features (weight loss, anemia, endoscopic abnormalities). ### Why Biopsy Is Superior to Serology Alone While intrinsic factor and anti-parietal cell antibodies are specific for autoimmune gastritis, they: 1. May be negative in seronegative pernicious anemia (10–40% of cases) 2. Do NOT exclude concurrent gastric cancer 3. Do NOT provide histological evidence of malignancy Biopsy is the only investigation that directly visualizes the mucosa and can definitively rule out malignancy. **Clinical Pearl:** The Sydney protocol recommends multiple biopsies from the antrum, body, and fundus to assess for intestinal metaplasia, dysplasia, and malignancy. A single biopsy may miss focal lesions. **Mnemonic:** **BIOPSY for Baseline** — When achlorhydria + weight loss + endoscopic changes are present, **BIOPSY** is the baseline investigation to rule out malignancy before attributing findings to benign autoimmune gastritis. [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.